United Therapeutics Corp. (UTHR)
488.51
+3.65
(+0.75%)
USD |
NASDAQ |
Dec 11, 16:00
488.67
+0.16
(+0.03%)
After-Hours: 20:00
United Therapeutics Research and Development Expense (TTM): 544.30M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Liquidia Corp. | 37.78M |
| Amgen, Inc. | 6.828B |
| Insmed, Inc. | 695.91M |
| Corcept Therapeutics, Inc. | 260.35M |
| Catalyst Pharmaceuticals, Inc. | 14.70M |